OLEG B SHPAK

Allopathic & Osteopathic Physicians|Internal Medicine LANHAM, MD NPI 1376546069

General Payments — all program years on this page

$2,934.43

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 168
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $342.18 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $342.1819

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $141.989
Acerta Pharma LLC $73.414
Lilly USA, LLC $29.301
CashFlow Solutions, LLC $25.491
Abbott Laboratories $22.461
Amgen Inc. $17.721
Exact Sciences Corporation $17.561
AIMMUNE THERAPEUTICS, INC. $14.261

By program year

Program yearAmountRecords
2018 $347.1722
2019 $563.6332
2020 $294.2315
2021 $550.7332
2022 $510.5531
2023 $325.9417
2024 $342.1819

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096570862 Novo Nordisk Inc $14.63 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096780803 Novo Nordisk Inc $23.92 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097091411 Novo Nordisk Inc $15.31 12/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097579138 Novo Nordisk Inc $15.79 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097592792 Novo Nordisk Inc $16.14 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097685416 Novo Nordisk Inc $19.53 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097691371 Novo Nordisk Inc $10.51 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097711552 Novo Nordisk Inc $9.75 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097781745 Novo Nordisk Inc $16.40 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105310741 AstraZeneca Pharmaceuticals LP $25.43 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105519515 AstraZeneca Pharmaceuticals LP $14.36 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105643218 AstraZeneca Pharmaceuticals LP $17.77 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105886011 AstraZeneca Pharmaceuticals LP $15.85 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114896911 Exact Sciences Corporation $17.56 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116122205 Amgen Inc. $17.72 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125034091 Abbott Laboratories $22.46 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135309691 Lilly USA, LLC $29.30 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139259893 CashFlow Solutions, LLC $25.49 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147012568 AIMMUNE THERAPEUTICS, INC. $14.26 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.